Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Cash from Operations (2017 - 2025)

Catheter Precision (VTAK) has disclosed Cash from Operations for 9 consecutive years, with 1516000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 47.07% to 1516000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8300000.0 through Dec 2025, up 10.47% year-over-year, with the annual reading at 8300000.0 for FY2025, 10.47% up from the prior year.
  • Cash from Operations for Q4 2025 was 1516000.0 at Catheter Precision, up from 2184000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 1516000.0 in Q4 2025, with the low at 12053000.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 4419150.0, with a median of 2944500.0 recorded in 2022.
  • Peak annual rise in Cash from Operations hit 83.89% in 2024, while the deepest fall reached 51.61% in 2024.
  • Over 5 years, Cash from Operations stood at 5711000.0 in 2021, then soared by 47.03% to 3025000.0 in 2022, then skyrocketed by 37.55% to 1889000.0 in 2023, then crashed by 51.61% to 2864000.0 in 2024, then skyrocketed by 47.07% to 1516000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 1516000.0, 2184000.0, and 2262000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.